Serum alpha-fetoprotein response can predict prognosis in hepatocellular carcinoma patients undergoing radiofrequency ablation therapy
W. Y. Kao, Y. Y. Chiou*, H. H. Hung, C. W. Su, Y. H. Chou, J. C. Wu, T. I. Huo, Y. H. Huang, W. C. Wu, H. C. Lin, S. D. Lee
*此作品的通信作者
研究成果: Article › 同行評審
39
引文
斯高帕斯（Scopus）